Luckys Pharma Lab Private Limited

BUDEFLO-G FORTE: Triple Therapy for Enhanced Respiratory Care

BUDEFLO-G FORTE, delivered through an advanced Keyhaler device, combines Glycopyrrolate 25 mcg, Formoterol 12 mcg, and Budesonide 400 mcg to provide superior management of severe asthma and chronic obstructive pulmonary disease (COPD). Glycopyrrolate acts as a long-acting muscarinic antagonist (LAMA), reducing airway constriction and improving airflow. Formoterol, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, offering quick relief from breathing difficulties. Budesonide, a powerful inhaled corticosteroid (ICS), reduces airway inflammation and prevents exacerbations. 

Salflo Nasal Spray is a saline nasal spray used to moisturize and relieve dry or irritated nasal passages. It contains a solution of sodium chloride (salt) in purified water and is free from any medications or additives. Saline nasal sprays are commonly used to alleviate symptoms associated with dry air, allergies, sinusitis, and nasal congestion.

Saline nasal spray works by:

• Moisturizing the nasal mucosa: The saline solution helps hydrate and lubricate the nasal passages, reducing dryness and irritation.
• Clearing mucus: The spray can help loosen and thin mucus, making it easier to expel from the nasal passages.
• Promoting nasal hygiene: Saline solution helps cleanse the nasal passages by washing away debris, allergens, and irritants.

Salflo Nasal Spray is indicated for:

• Relief of dry nasal passages
• Alleviation of nasal congestion
• Relief of symptoms associated with allergies and sinusitis
• Maintenance of nasal hygiene

Telford - AM Tablet Overview:

Telford - AM Tablet is a combination medication designed to manage high blood pressure (hypertension). It contains two active ingredients that work synergistically to lower blood pressure by relaxing blood vessels, thus easing the heart's workload and reducing the risk of heart attack or stroke.

Administration:

• Telford - AM Tablet can be taken on an empty stomach or with food, but it is recommended to take it consistently at the same time each day as prescribed by your doctor.
• Dosage will vary depending on your individual condition and response to the medication. It's important to adhere to the prescribed regimen.
• Even if you feel well, continue taking the medication as directed. Consistent use is crucial for effectively reducing the risk of heart attack or stroke.

Treatment of Hypertension:

• Telford - AM Tablet effectively treats hypertension, a condition characterized by elevated blood pressure levels.
• The combination of active ingredients in this medication works through different mechanisms to lower blood pressure. By relaxing blood vessels and facilitating smoother blood flow, it reduces the strain on the heart and decreases the risk of cardiovascular complications such as heart attack, stroke, or kidney problems.
• While you may not feel an immediate effect from taking this medication, its long-term benefits lie in maintaining stable blood pressure levels and preserving overall health.

Leval 0.31 is a respiratory solution containing levosalbutamol, a selective beta-2 adrenergic agonist used for the treatment of bronchospasm associated with conditions such as asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol is the active enantiomer of salbutamol, which means it specifically targets beta-2 receptors in the lungs, leading to smooth muscle relaxation and subsequent bronchodilation. This action helps to quickly open the airways, making breathing easier and providing relief from symptoms such as wheezing, shortness of breath, and chest tightness.

Administered via a nebulizer, Leval 0.31 is particularly effective for patients who may have difficulty using traditional inhalers, including young children, elderly individuals, or those experiencing severe respiratory distress. The nebulizer converts the solution into a fine mist, ensuring that the medication reaches deep into the lungs for optimal absorption and rapid onset of action.

Leval 0.31 is typically used as needed to relieve acute bronchospasm or as part of a maintenance regimen to prevent symptoms triggered by exercise or environmental factors. Its rapid action and effectiveness in opening airways make it an essential medication for managing acute episodes of respiratory distress.

Budeflo G is an innovative rotacap formulation that combines glycopyrronium, formoterol fumarate, and budesonide, tailored for the management of chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Each of these active ingredients plays a crucial role in providing comprehensive respiratory support.

Glycopyrronium is a long-acting muscarinic antagonist (LAMA) that works by blocking muscarinic receptors in the airways. This action helps to relax the muscles around the airways, reducing bronchoconstriction and improving airflow. By preventing acetylcholine from binding to these receptors, glycopyrronium promotes sustained bronchodilation, which is essential for managing COPD symptoms such as shortness of breath and wheezing.

Formoterol Fumarate, a long-acting beta-agonist (LABA), complements glycopyrronium's action by further relaxing the airway smooth muscles. It works by stimulating beta-2 adrenergic receptors, which enhances bronchodilation and helps to open up the airways. Formoterol fumarate provides rapid onset of action and sustained relief, making it effective in managing symptoms of COPD.

Budesonide is a potent corticosteroid that acts locally in the lungs to reduce inflammation. By inhibiting the production and release of inflammatory mediators, budesonide helps to decrease swelling and mucus production in the airways. This anti-inflammatory effect not only provides long-term control of COPD symptoms but also helps to prevent exacerbations.

Budeflo G is administered using a rotacap device, ensuring efficient delivery of the medication directly into the lungs. This method allows for optimal absorption of all three active ingredients, maximizing therapeutic benefits and minimizing systemic side effects.

Budeflo Forte is a combination rotacap containing glycopyrronium and formoterol fumarate, specifically formulated for the effective management of chronic obstructive pulmonary disease (COPD). Glycopyrronium is a long-acting muscarinic antagonist (LAMA) that works by inhibiting muscarinic receptors in the airway smooth muscle, leading to bronchodilation and reduced airway resistance. Formoterol fumarate is a long-acting beta-agonist (LABA) that relaxes the muscles around the airways, providing prolonged bronchodilation and facilitating easier breathing.

The combination of glycopyrronium and formoterol fumarate in Budeflo Forte offers a synergistic effect, ensuring both rapid and sustained relief from COPD symptoms such as shortness of breath, wheezing, and chronic cough. Glycopyrronium helps to keep the airways open by preventing bronchoconstriction, while formoterol provides continuous bronchodilation, improving lung function and enhancing overall respiratory capacity.

Budeflo Forte rotacaps are used with a Rotahaler device, which delivers the medication in a fine powder form directly to the lungs. This method ensures efficient drug delivery and optimal therapeutic effects. Typically, Budeflo Forte is administered twice daily, providing round-the-clock management of COPD symptoms.

Product Introduction: Telford H Tablet

Telford H Tablet is a combination medication formulated with two active ingredients aimed at effectively controlling high blood pressure. Typically prescribed when monotherapy is insufficient in managing blood pressure levels, Telford H Tablet plays a crucial role in reducing the risk of future heart attacks or strokes.

Usage Instructions:

• Telford H Tablet can be taken with or without food, offering flexibility in administration.
• The prescribed dosage of Telford H Tablet will be determined by your healthcare provider based on individual response to the medication and underlying medical condition. Consistency in daily intake, preferably at the same time each day, is advisable.
• It is imperative to continue taking Telford H Tablet until instructed otherwise by your doctor. Abrupt discontinuation may result in adverse cardiovascular events.
• Due to the diuretic component present in Telford H Tablet, increased urination may occur. To minimize disruption to sleep patterns, it is recommended to avoid ingestion within four hours of bedtime.
• Regular and consistent usage of Telford H Tablet, even in the absence of symptoms, is essential to maximize therapeutic benefits. Ceasing the medication without medical supervision may elevate the risk of heart-related complications.

Lucky Pharma Lab Pvt Ltd is excited to extend franchise opportunities in Respules across India. Respules, also known as inhalation solutions, are essential for managing respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. As a trusted pharmaceutical company dedicated to enhancing respiratory health, we offer franchise partnerships to empower entrepreneurs and healthcare professionals in delivering high-quality Respules to patients nationwide.

By joining hands with Lucky Pharma Lab Pvt Ltd, franchisees gain access to a comprehensive range of Respules renowned for their efficacy, safety, and reliability. Our commitment to quality assurance ensures that patients receive top-notch respiratory medications, contributing to better health outcomes and improved quality of life.

Product Introduction

Vilford 50/500 Tablet is a combination medication formulated to regulate high blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. This medication aids in preventing serious complications associated with diabetes, such as kidney damage, blindness, and reducing the risk of cardiovascular events like heart attack or stroke.

Indications

Vilford 50/500 Tablet is indicated for the management of high blood sugar levels in individuals with type 2 diabetes mellitus.

Composition

Vilford 50/500 Tablet contains a combination of two active ingredients that work synergistically to control blood sugar levels.

Key Ingredients

• Metformin Hydrochloride (50 mg)
• Glimepiride (500 mg)

Mode of Action

Metformin works by decreasing the production of glucose in the liver and improving insulin sensitivity in the body. Glimepiride stimulates the release of insulin from the pancreas, thereby reducing blood sugar levels.

Efurt 250/500 is a broad-spectrum antibiotic medication containing Cefuroxime Axetil, available in 250 mg and 500 mg tablet formulations. Cefuroxime Axetil is a cephalosporin antibiotic that works by disrupting the synthesis of bacterial cell walls, ultimately leading to the destruction of bacteria. This makes Efurt 250/500 highly effective against a wide range of bacterial infections.

Efurt 250/500 is used to treat various infections, including those affecting the respiratory tract (such as bronchitis and pneumonia), urinary tract infections, skin and soft tissue infections, and infections of the ear, nose, and throat. Its broad spectrum of activity makes it suitable for managing both uncomplicated and more severe infections caused by susceptible bacteria.

The dosage flexibility of Efurt 250/500 allows for tailored treatment plans based on the severity of the infection and the patient’s overall health. By providing a reliable and effective antibiotic option, Efurt 250/500 helps ensure prompt recovery from bacterial infections and prevents complications associated with untreated infections.

CILAST 1GM Injection combines Imipenem (500 mg) and Cilastatin (500 mg), offering a powerful broad-spectrum antibiotic solution for severe bacterial infections. Imipenem, a carbapenem-class antibiotic, effectively targets and destroys a wide range of gram-positive and gram-negative bacteria, including resistant strains. 

Levoice A2 contains Acebrophylline 100 mg and Acetylcysteine 600 mg, a combination used primarily in the management of respiratory conditions like chronic obstructive pulmonary disease (COPD) and bronchial asthma.

• Acebrophylline 100 mg: A bronchodilator with mucolytic and anti-inflammatory properties. It helps in relaxing the smooth muscles of the airways, reducing inflammation, and promoting mucus clearance, thus improving breathing.

• Acetylcysteine 600 mg: A mucolytic agent that breaks down thick mucus, making it easier to expel. It helps in reducing the viscosity of secretions, which facilitates better lung function and helps in alleviating symptoms like cough and congestion.

Levoice A2 contains Acebrophylline 100 mg and Acetylcysteine 600 mg, a combination used primarily in the management of respiratory conditions like chronic obstructive pulmonary disease (COPD) and bronchial asthma.

• Acebrophylline 100 mg: A bronchodilator with mucolytic and anti-inflammatory properties. It helps in relaxing the smooth muscles of the airways, reducing inflammation, and promoting mucus clearance, thus improving breathing.

• Acetylcysteine 600 mg: A mucolytic agent that breaks down thick mucus, making it easier to expel. It helps in reducing the viscosity of secretions, which facilitates better lung function and helps in alleviating symptoms like cough and congestion.

Levoice A2 contains Acebrophylline 100 mg and Acetylcysteine 600 mg, a combination used primarily in the management of respiratory conditions like chronic obstructive pulmonary disease (COPD) and bronchial asthma.

• Acebrophylline 100 mg: A bronchodilator with mucolytic and anti-inflammatory properties. It helps in relaxing the smooth muscles of the airways, reducing inflammation, and promoting mucus clearance, thus improving breathing.

• Acetylcysteine 600 mg: A mucolytic agent that breaks down thick mucus, making it easier to expel. It helps in reducing the viscosity of secretions, which facilitates better lung function and helps in alleviating symptoms like cough and congestion.